Table 2 COVID-19 vaccination status prior to SARS-CoV-2 diagnosis.

From: Improved outcome of COVID-19 over time in patients treated with CAR T-cell therapy: Update of the European COVID-19 multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party (IDWP) and the European Hematology Association (EHA) Lymphoma Group

 

2020 (N = 39)

2021 (N = 35)

2022 (N = 106)

Total (N = 180)

P value Δ 2021 versus 2022

COVID-19 vaccination status

 

No vaccination

39 (100.0)

21 (60.0)

15 (14.2)

75 (41.7)

 

1–2 vaccinations

0 (0.0)

7 (20.0)

20 (18.9)

27 (15.0)

 

≥3 vaccinations

0 (0.0)

1 (2.9)

46 (43.4)

47 (26.1)

<0.0001

Unknown

0 (0.0)

6 (17.1)

25 (23.6)

31 (17.2)